US drug stocks fall as FDA vaccine chief ousted amid Trump health overhaul
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year ...
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks’s resignation in protest of Robert ...
BioSpace1h
Marks’ Sudden Departure From FDA Magnifies Uncertainty, Sends Biopharma Shares Down
The stock market—and biotech insiders—reacted negatively to the allegedly forced resignation of CBER Director Peter Marks, ...
Moderna, biotech stocks slide on resignation of FDA official Peter Marks
The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.
STAT1h
Peter Marks, FDA’s top vaccine regulator, forced out
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
Biotech stocks tumble on reports FDA's top vaccine regulator to leave
Peter Marks, who played a key role in U.S. President Donald Trump's first term in developing COVID-19 vaccines, will leave ...
Korea Investment CORP Increases Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
Korea Investment CORP grew its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 39,289 shares ...
GEN - Genetic Engineering and Biotechnology News9h
Industry Voices Alarm as Peter Marks Departs FDA
The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.
House Republican warns 23andMe and Trump administration to keep genetic data out of hands of ‘bad actors’
Rep. Stephanie Bice (R-OK) is asking the Trump administration to monitor the selling of genetic data by the recently bankrupted biotechnology company 23andme to ensure that Americans’ information ...
Is United Therapeutics (UTHR) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal ...
ValueTheMarkets Insights: While Big Pharma Stalls, One Small-Cap Breaks Out
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...